Click for best price
Targeted Drugs for Allergic Diseases Market Size, Share 2024
This research report provides a comprehensive analysis of the Targeted Drugs for Allergic Diseases market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Targeted Drugs for Allergic Diseases market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Targeted Drugs for Allergic Diseases, challenges faced by the industry, and potential opportunities for market players.
The global Targeted Drugs for Allergic Diseases market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Targeted Drugs for Allergic Diseases market presents opportunities for various stakeholders, including Atopic Dermatitis, Asthma. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Targeted Drugs for Allergic Diseases market. Additionally, the growing consumer demand present avenues for market expansion.
The global Targeted Drugs for Allergic Diseases market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Targeted Drugs for Allergic Diseases market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Targeted Drugs for Allergic Diseases market.
Market Overview: The report provides a comprehensive overview of the Targeted Drugs for Allergic Diseases market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., IL-4R, TSLP), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Targeted Drugs for Allergic Diseases market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Targeted Drugs for Allergic Diseases market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Targeted Drugs for Allergic Diseases market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Targeted Drugs for Allergic Diseases market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Targeted Drugs for Allergic Diseases market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Targeted Drugs for Allergic Diseases market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Targeted Drugs for Allergic Diseases, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Targeted Drugs for Allergic Diseases market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Targeted Drugs for Allergic Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- IL-4R
- TSLP
- IL-5
- JAK
- IgE
- IL-33
- Others
Market segment by Application
- Atopic Dermatitis
- Asthma
- Chronic Sinusitis with Nasal Polyps
- Chronic Obstructive Pulmonary Disease
- Others
Global Targeted Drugs for Allergic Diseases Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Sanofi
- Novartis
- GSK
- Amgen
- AstraZeneca
- Biosion
- Pfizer
- UCB
- Otsuka Pharmaceutical
- Roche
- Keymed Biosciences
- Mabpharm
- Genrix Bio
- Dragon Boat Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Sunshine Guojian
- Qyuns Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Drugs for Allergic Diseases, market overview.
Chapter 2: Global Targeted Drugs for Allergic Diseases market size in revenue.
Chapter 3: Detailed analysis of Targeted Drugs for Allergic Diseases company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Drugs for Allergic Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Targeted Drugs for Allergic Diseases Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
131 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeted Drugs for Allergic Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Drugs for Allergic Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Drugs for Allergic Diseases Overall Market Size
2.1 Global Targeted Drugs for Allergic Diseases Market Size: 2023 VS 2030
2.2 Global Targeted Drugs for Allergic Diseases Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Drugs for Allergic Diseases Players in Global Market
3.2 Top Global Targeted Drugs for Allergic Diseases Companies Ranked by Revenue
3.3 Global Targeted Drugs for Allergic Diseases Revenue by Companies
3.4 Top 3 and Top 5 Targeted Drugs for Allergic Diseases Companies in Global Market, by Revenue in 2023
3.5 Global Companies Targeted Drugs for Allergic Diseases Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Drugs for Allergic Diseases Players in Global Market
3.6.1 List of Global Tier 1 Targeted Drugs for Allergic Diseases Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Drugs for Allergic Diseases Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeted Drugs for Allergic Diseases Market Size Markets, 2023 & 2030
4.1.2 IL-4R
4.1.3 TSLP
4.1.4 IL-5
4.1.5 JAK
4.1.6 IgE
4.1.7 IL-33
4.1.8 Others
4.2 By Type - Global Targeted Drugs for Allergic Diseases Revenue & Forecasts
4.2.1 By Type - Global Targeted Drugs for Allergic Diseases Revenue, 2019-2024
4.2.2 By Type - Global Targeted Drugs for Allergic Diseases Revenue, 2025-2030
4.2.3 By Type - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Drugs for Allergic Diseases Market Size, 2023 & 2030
5.1.2 Atopic Dermatitis
5.1.3 Asthma
5.1.4 Chronic Sinusitis with Nasal Polyps
5.1.5 Chronic Obstructive Pulmonary Disease
5.1.6 Others
5.2 By Application - Global Targeted Drugs for Allergic Diseases Revenue & Forecasts
5.2.1 By Application - Global Targeted Drugs for Allergic Diseases Revenue, 2019-2024
5.2.2 By Application - Global Targeted Drugs for Allergic Diseases Revenue, 2025-2030
5.2.3 By Application - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Targeted Drugs for Allergic Diseases Market Size, 2023 & 2030
6.2 By Region - Global Targeted Drugs for Allergic Diseases Revenue & Forecasts
6.2.1 By Region - Global Targeted Drugs for Allergic Diseases Revenue, 2019-2024
6.2.2 By Region - Global Targeted Drugs for Allergic Diseases Revenue, 2025-2030
6.2.3 By Region - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Targeted Drugs for Allergic Diseases Revenue, 2019-2030
6.3.2 US Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.3.3 Canada Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.3.4 Mexico Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Targeted Drugs for Allergic Diseases Revenue, 2019-2030
6.4.2 Germany Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.3 France Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.4 U.K. Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.5 Italy Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.6 Russia Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.7 Nordic Countries Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.4.8 Benelux Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Targeted Drugs for Allergic Diseases Revenue, 2019-2030
6.5.2 China Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.5.3 Japan Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.5.4 South Korea Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.5.5 Southeast Asia Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.5.6 India Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Targeted Drugs for Allergic Diseases Revenue, 2019-2030
6.6.2 Brazil Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.6.3 Argentina Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Drugs for Allergic Diseases Revenue, 2019-2030
6.7.2 Turkey Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.7.3 Israel Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.7.4 Saudi Arabia Targeted Drugs for Allergic Diseases Market Size, 2019-2030
6.7.5 UAE Targeted Drugs for Allergic Diseases Market Size, 2019-2030
7 Targeted Drugs for Allergic Diseases Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Targeted Drugs for Allergic Diseases Major Product Offerings
7.1.4 Sanofi Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.1.5 Sanofi Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Targeted Drugs for Allergic Diseases Major Product Offerings
7.2.4 Novartis Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.2.5 Novartis Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Targeted Drugs for Allergic Diseases Major Product Offerings
7.3.4 GSK Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.3.5 GSK Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Targeted Drugs for Allergic Diseases Major Product Offerings
7.4.4 Amgen Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.4.5 Amgen Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Targeted Drugs for Allergic Diseases Major Product Offerings
7.5.4 AstraZeneca Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Biosion
7.6.1 Biosion Company Summary
7.6.2 Biosion Business Overview
7.6.3 Biosion Targeted Drugs for Allergic Diseases Major Product Offerings
7.6.4 Biosion Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.6.5 Biosion Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Targeted Drugs for Allergic Diseases Major Product Offerings
7.7.4 Pfizer Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 UCB
7.8.1 UCB Company Summary
7.8.2 UCB Business Overview
7.8.3 UCB Targeted Drugs for Allergic Diseases Major Product Offerings
7.8.4 UCB Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.8.5 UCB Key News & Latest Developments
7.9 Otsuka Pharmaceutical
7.9.1 Otsuka Pharmaceutical Company Summary
7.9.2 Otsuka Pharmaceutical Business Overview
7.9.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Major Product Offerings
7.9.4 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.9.5 Otsuka Pharmaceutical Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Targeted Drugs for Allergic Diseases Major Product Offerings
7.10.4 Roche Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
7.11 Keymed Biosciences
7.11.1 Keymed Biosciences Company Summary
7.11.2 Keymed Biosciences Business Overview
7.11.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Major Product Offerings
7.11.4 Keymed Biosciences Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.11.5 Keymed Biosciences Key News & Latest Developments
7.12 Mabpharm
7.12.1 Mabpharm Company Summary
7.12.2 Mabpharm Business Overview
7.12.3 Mabpharm Targeted Drugs for Allergic Diseases Major Product Offerings
7.12.4 Mabpharm Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.12.5 Mabpharm Key News & Latest Developments
7.13 Genrix Bio
7.13.1 Genrix Bio Company Summary
7.13.2 Genrix Bio Business Overview
7.13.3 Genrix Bio Targeted Drugs for Allergic Diseases Major Product Offerings
7.13.4 Genrix Bio Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.13.5 Genrix Bio Key News & Latest Developments
7.14 Dragon Boat Pharmaceutical
7.14.1 Dragon Boat Pharmaceutical Company Summary
7.14.2 Dragon Boat Pharmaceutical Business Overview
7.14.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Major Product Offerings
7.14.4 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.14.5 Dragon Boat Pharmaceutical Key News & Latest Developments
7.15 Jiangsu Hengrui Pharmaceuticals
7.15.1 Jiangsu Hengrui Pharmaceuticals Company Summary
7.15.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.15.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Major Product Offerings
7.15.4 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.15.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
7.16 Sunshine Guojian
7.16.1 Sunshine Guojian Company Summary
7.16.2 Sunshine Guojian Business Overview
7.16.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Major Product Offerings
7.16.4 Sunshine Guojian Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.16.5 Sunshine Guojian Key News & Latest Developments
7.17 Qyuns Therapeutics
7.17.1 Qyuns Therapeutics Company Summary
7.17.2 Qyuns Therapeutics Business Overview
7.17.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Major Product Offerings
7.17.4 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Revenue in Global Market (2019-2024)
7.17.5 Qyuns Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Targeted Drugs for Allergic Diseases Market Opportunities & Trends in Global Market
Table 2. Targeted Drugs for Allergic Diseases Market Drivers in Global Market
Table 3. Targeted Drugs for Allergic Diseases Market Restraints in Global Market
Table 4. Key Players of Targeted Drugs for Allergic Diseases in Global Market
Table 5. Top Targeted Drugs for Allergic Diseases Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Targeted Drugs for Allergic Diseases Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Targeted Drugs for Allergic Diseases Revenue Share by Companies, 2019-2024
Table 8. Global Companies Targeted Drugs for Allergic Diseases Product Type
Table 9. List of Global Tier 1 Targeted Drugs for Allergic Diseases Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Drugs for Allergic Diseases Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Targeted Drugs for Allergic Diseases Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Targeted Drugs for Allergic Diseases Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Targeted Drugs for Allergic Diseases Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Targeted Drugs for Allergic Diseases Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Targeted Drugs for Allergic Diseases Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Targeted Drugs for Allergic Diseases Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2025-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Targeted Drugs for Allergic Diseases Product Offerings
Table 32. Sanofi Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 33. Sanofi Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Targeted Drugs for Allergic Diseases Product Offerings
Table 36. Novartis Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 37. Novartis Key News & Latest Developments
Table 38. GSK Company Summary
Table 39. GSK Targeted Drugs for Allergic Diseases Product Offerings
Table 40. GSK Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 41. GSK Key News & Latest Developments
Table 42. Amgen Company Summary
Table 43. Amgen Targeted Drugs for Allergic Diseases Product Offerings
Table 44. Amgen Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 45. Amgen Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Targeted Drugs for Allergic Diseases Product Offerings
Table 48. AstraZeneca Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Biosion Company Summary
Table 51. Biosion Targeted Drugs for Allergic Diseases Product Offerings
Table 52. Biosion Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 53. Biosion Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Targeted Drugs for Allergic Diseases Product Offerings
Table 56. Pfizer Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. UCB Company Summary
Table 59. UCB Targeted Drugs for Allergic Diseases Product Offerings
Table 60. UCB Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 61. UCB Key News & Latest Developments
Table 62. Otsuka Pharmaceutical Company Summary
Table 63. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Offerings
Table 64. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 65. Otsuka Pharmaceutical Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Targeted Drugs for Allergic Diseases Product Offerings
Table 68. Roche Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 69. Roche Key News & Latest Developments
Table 70. Keymed Biosciences Company Summary
Table 71. Keymed Biosciences Targeted Drugs for Allergic Diseases Product Offerings
Table 72. Keymed Biosciences Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 73. Keymed Biosciences Key News & Latest Developments
Table 74. Mabpharm Company Summary
Table 75. Mabpharm Targeted Drugs for Allergic Diseases Product Offerings
Table 76. Mabpharm Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 77. Mabpharm Key News & Latest Developments
Table 78. Genrix Bio Company Summary
Table 79. Genrix Bio Targeted Drugs for Allergic Diseases Product Offerings
Table 80. Genrix Bio Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 81. Genrix Bio Key News & Latest Developments
Table 82. Dragon Boat Pharmaceutical Company Summary
Table 83. Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Product Offerings
Table 84. Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 85. Dragon Boat Pharmaceutical Key News & Latest Developments
Table 86. Jiangsu Hengrui Pharmaceuticals Company Summary
Table 87. Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Product Offerings
Table 88. Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 89. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
Table 90. Sunshine Guojian Company Summary
Table 91. Sunshine Guojian Targeted Drugs for Allergic Diseases Product Offerings
Table 92. Sunshine Guojian Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 93. Sunshine Guojian Key News & Latest Developments
Table 94. Qyuns Therapeutics Company Summary
Table 95. Qyuns Therapeutics Targeted Drugs for Allergic Diseases Product Offerings
Table 96. Qyuns Therapeutics Targeted Drugs for Allergic Diseases Revenue (US$, Mn) & (2019-2024)
Table 97. Qyuns Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Targeted Drugs for Allergic Diseases Segment by Type in 2023
Figure 2. Targeted Drugs for Allergic Diseases Segment by Application in 2023
Figure 3. Global Targeted Drugs for Allergic Diseases Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Targeted Drugs for Allergic Diseases Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Targeted Drugs for Allergic Diseases Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Drugs for Allergic Diseases Revenue in 2023
Figure 8. By Type - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 9. By Application - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 10. By Type - Global Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 12. By Application - Global Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 14. By Region - Global Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 15. By Country - North America Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 16. US Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 20. Germany Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 21. France Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 28. China Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 32. India Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 34. Brazil Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Targeted Drugs for Allergic Diseases Revenue Market Share, 2019-2030
Figure 37. Turkey Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Targeted Drugs for Allergic Diseases Revenue, (US$, Mn), 2019-2030
Figure 41. Sanofi Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Novartis Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GSK Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Amgen Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AstraZeneca Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Biosion Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. UCB Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Roche Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Keymed Biosciences Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Mabpharm Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Genrix Bio Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Sunshine Guojian Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Qyuns Therapeutics Targeted Drugs for Allergic Diseases Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
